Target intelligence / Profile preview

Tetanus toxin heavy chain C-terminal domain (TeNT-Hc) (TeNT-Hc)

Target
TeNT-Hc
Molecular classification
Bacterial toxin domain, Protein-binding domain, Ganglioside-binding protein
01

Overview

The Tetanus toxin heavy chain C-terminal domain (TeNT-Hc), also known as Fragment C, is a 50 kDa protein domain derived from the tetanus neurotoxin produced by Clostridium tetani (UniProt P04958). It serves as the primary receptor-binding component, facilitating the toxin's attachment to the presynaptic membrane of motor neurons through a dual-receptor mechanism involving polysialogangliosides (GD1b, GT1b) and protein receptors such as nidogen-1 and nidogen-2 (Bercsenyi et al., 2014). Following binding, TeNT-Hc mediates the internalization and retrograde axonal transport of the toxin to the spinal cord, a process critical for the pathogenesis of tetanus (Lalli et al., 2003). In clinical practice, this domain is the target of neutralizing antibodies induced by the tetanus toxoid vaccine and those provided by tetanus immune globulin (StatPearls, 2023). Beyond its role in disease, TeNT-Hc is extensively utilized in biomedical research as a non-toxic molecular vehicle for delivering therapeutic agents, such as enzymes or genetic material, directly into the central nervous system (Rossetto et al., 2014). Its high affinity for neurons and ability to bypass the blood-brain barrier via retrograde transport make it a significant tool for treating neurodegenerative conditions in experimental models.

Other names
Fragment CTTCTeNT-HcTetanus toxin Hc fragmentTetanus toxin receptor-binding domain
02

Mechanism of action

Neutralization of the binding domain to prevent neuronal entry and retrograde transport.

03

Biological functions

Neuronal bindingRetrograde axonal transportReceptor-mediated endocytosis
04

Disease associations

Infection
05

Safety considerations

ImmunogenicityHypersensitivityPotential for off-target neuronal delivery in carrier applications
06

Interacting drugs

Tetanus toxoid

1 more in the full profile.

07

Biomarkers

Anti-tetanus antibody titer

Beyond the preview

Go deeper on Tetanus toxin heavy chain C-terminal domain (TeNT-Hc) (TeNT-Hc).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetanus toxin heavy chain C-terminal domain (TeNT-Hc) (TeNT-Hc).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call